News items related to: Kazakhstan
-
MMA’s partners in Kazakhstan call for systemic changes to the country’s intellectual property and access to medicines framework in their annual report
Answer Foundation and Antihepatitis C Foundation, MMA’s partners in Kazakhstan, with technical support from ITPC-Ru, recently launched a comprehensive Annual...
-
No one left behind: generational transfer of knowledge as essential for universal quality treatment
In Kazakhstan, many people living with HIV waited for years to access treatment with old generation antiretrovirals (ARVs). These medicines...
-
Access to optimal treatment for HIV in Kazakhstan: as prices go down, so does stigma
MMA’s campaign partner in Kazakhstan, Answer, focuses on reducing prices, and improving access to optimal treatment for HCV, viral hepatitis...
-
Russian Federation’s updated patent law puts public health first
The Russian Federation parliament voted this week (13 April 2021) to enshrine into the law the country’s right to enact...
-
GALLERY: International Women’s Day 2021
Around this time last year, before many countries went into their first COVID-19 related lockdown, Make Medicines Affordable met with...
-
Letter to ViiV Healthcare: No more time to waste – increase access to dolutegravir in Eastern Europe and Central Asia
Dolutegravir is an essential drug in HIV treatment, recommended by the World Health Organization (WHO). Despite the drug being approved...
-
Activists urge Eurasian states to order more affordable medicines, after HIV patent is dropped
AbbVie has waived its patent rights for HIV drug, lopinavir/ritonavir (LPV/r), in many parts of the world, including for the...
